JP2014513122A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014513122A5 JP2014513122A5 JP2014509340A JP2014509340A JP2014513122A5 JP 2014513122 A5 JP2014513122 A5 JP 2014513122A5 JP 2014509340 A JP2014509340 A JP 2014509340A JP 2014509340 A JP2014509340 A JP 2014509340A JP 2014513122 A5 JP2014513122 A5 JP 2014513122A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- carboxamide
- dihydroisoxazol
- methoxybenzyl
- fluoro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 benzo [1,4] oxazin-3-oneyl Chemical group 0.000 claims 203
- HKSQZEGSMBFHGC-UHFFFAOYSA-N pyrimidine-4-carboxamide Chemical compound NC(=O)C1=CC=NC=N1 HKSQZEGSMBFHGC-UHFFFAOYSA-N 0.000 claims 45
- 150000001875 compounds Chemical class 0.000 claims 26
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 22
- 125000004076 pyridyl group Chemical group 0.000 claims 21
- 125000001544 thienyl group Chemical group 0.000 claims 17
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 15
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 15
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 15
- 125000003226 pyrazolyl group Chemical group 0.000 claims 13
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 12
- 125000002757 morpholinyl group Chemical group 0.000 claims 12
- 125000002098 pyridazinyl group Chemical group 0.000 claims 12
- 125000000984 3-chloro-4-fluorobenzyl group Chemical group [H]C1=C(F)C(Cl)=C([H])C(=C1[H])C([H])([H])* 0.000 claims 11
- 125000002883 imidazolyl group Chemical group 0.000 claims 11
- 125000000842 isoxazolyl group Chemical group 0.000 claims 11
- 125000005494 pyridonyl group Chemical group 0.000 claims 11
- 150000003857 carboxamides Chemical class 0.000 claims 10
- 125000002971 oxazolyl group Chemical group 0.000 claims 10
- 125000003386 piperidinyl group Chemical group 0.000 claims 10
- 125000006509 3,4-difluorobenzyl group Chemical group [H]C1=C(F)C(F)=C([H])C(=C1[H])C([H])([H])* 0.000 claims 9
- 125000002393 azetidinyl group Chemical group 0.000 claims 9
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 9
- 125000000168 pyrrolyl group Chemical group 0.000 claims 9
- 125000003831 tetrazolyl group Chemical group 0.000 claims 9
- 125000004568 thiomorpholinyl group Chemical group 0.000 claims 9
- 125000001425 triazolyl group Chemical group 0.000 claims 9
- 125000005940 1,4-dioxanyl group Chemical group 0.000 claims 8
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 claims 8
- 125000001786 isothiazolyl group Chemical group 0.000 claims 8
- 125000001715 oxadiazolyl group Chemical group 0.000 claims 8
- 125000003373 pyrazinyl group Chemical group 0.000 claims 8
- 125000000335 thiazolyl group Chemical group 0.000 claims 8
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 7
- 229910052794 bromium Inorganic materials 0.000 claims 7
- 229910052801 chlorine Inorganic materials 0.000 claims 7
- 229910052731 fluorine Inorganic materials 0.000 claims 7
- 125000002541 furyl group Chemical group 0.000 claims 7
- 125000004284 isoxazol-3-yl group Chemical group [H]C1=C([H])C(*)=NO1 0.000 claims 7
- 125000001113 thiadiazolyl group Chemical group 0.000 claims 7
- 125000004176 4-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1F)C([H])([H])* 0.000 claims 6
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 claims 6
- SSFPLTJTUJJJML-UHFFFAOYSA-N OC(=O)C(F)(F)F.NC(=O)C1=CC=NC=N1 Chemical compound OC(=O)C(F)(F)F.NC(=O)C1=CC=NC=N1 SSFPLTJTUJJJML-UHFFFAOYSA-N 0.000 claims 6
- 125000000623 heterocyclic group Chemical group 0.000 claims 6
- 125000004193 piperazinyl group Chemical group 0.000 claims 6
- 125000001072 heteroaryl group Chemical group 0.000 claims 5
- 229910052739 hydrogen Inorganic materials 0.000 claims 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 5
- VUMINWLDNHKRNZ-PUCZYUMASA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[(5s)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@H](ON=2)[C@@H]2OC[C@@H](CO)OC2)=C1 VUMINWLDNHKRNZ-PUCZYUMASA-N 0.000 claims 5
- 125000001624 naphthyl group Chemical group 0.000 claims 5
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 claims 5
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 claims 5
- 125000001424 substituent group Chemical group 0.000 claims 5
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims 5
- 125000003118 aryl group Chemical group 0.000 claims 4
- 125000005334 azaindolyl group Chemical group N1N=C(C2=CC=CC=C12)* 0.000 claims 4
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims 4
- 125000005605 benzo group Chemical group 0.000 claims 4
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims 4
- 125000005874 benzothiadiazolyl group Chemical group 0.000 claims 4
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims 4
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 claims 4
- 125000001041 indolyl group Chemical group 0.000 claims 4
- VUMINWLDNHKRNZ-WVFSVQOHSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[(5s)-5-[(2s,5s)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@H](ON=2)[C@H]2OC[C@H](CO)OC2)=C1 VUMINWLDNHKRNZ-WVFSVQOHSA-N 0.000 claims 4
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 claims 4
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims 4
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 3
- 125000006497 3-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C(OC([H])([H])[H])=C1[H])C([H])([H])* 0.000 claims 3
- POCGPTVKWWVDHU-CAYVGHNUSA-N n-[(3-chloro-4-fluorophenyl)methyl]-6-[(5s)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@@H]1[C@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=C(Cl)C(F)=CC=2)O[C@H](CO)CO1 POCGPTVKWWVDHU-CAYVGHNUSA-N 0.000 claims 3
- VUMINWLDNHKRNZ-XMDBHEJHSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[(5r)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@@H](ON=2)[C@@H]2OC[C@@H](CO)OC2)=C1 VUMINWLDNHKRNZ-XMDBHEJHSA-N 0.000 claims 3
- RSJSHDKJJMWRIK-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[5-(6-methoxypyridazin-3-yl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound N1=NC(OC)=CC=C1C1ON=C(C=2N=C(C)N=C(C=2)C(=O)NCC=2C=C(OC)C(F)=CC=2)C1 RSJSHDKJJMWRIK-UHFFFAOYSA-N 0.000 claims 3
- 125000004306 triazinyl group Chemical group 0.000 claims 3
- DCOFGLGEIUURAQ-SLFFLAALSA-N (2r,5s)-5-[(5s)-3-[6-[(4-fluoro-3-methoxyphenyl)methylcarbamoyl]-2-methylpyrimidin-4-yl]-4,5-dihydro-1,2-oxazol-5-yl]-1,4-dioxane-2-carboxylic acid Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@H](ON=2)[C@H]2OC[C@@H](OC2)C(O)=O)=C1 DCOFGLGEIUURAQ-SLFFLAALSA-N 0.000 claims 2
- DCOFGLGEIUURAQ-ZCNNSNEGSA-N (2s,5r)-5-[(5s)-3-[6-[(4-fluoro-3-methoxyphenyl)methylcarbamoyl]-2-methylpyrimidin-4-yl]-4,5-dihydro-1,2-oxazol-5-yl]-1,4-dioxane-2-carboxylic acid Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@H](ON=2)[C@@H]2OC[C@H](OC2)C(O)=O)=C1 DCOFGLGEIUURAQ-ZCNNSNEGSA-N 0.000 claims 2
- 125000004504 1,2,4-oxadiazolyl group Chemical group 0.000 claims 2
- 125000001376 1,2,4-triazolyl group Chemical group N1N=C(N=C1)* 0.000 claims 2
- DRYMMXUBDRJPDS-UHFFFAOYSA-N 2-hydroxy-2-methylpropanamide Chemical compound CC(C)(O)C(N)=O DRYMMXUBDRJPDS-UHFFFAOYSA-N 0.000 claims 2
- UPCUZOMSXKDEHA-UHFFFAOYSA-N 6-(5-cyclohexyl-4,5-dihydro-1,2-oxazol-3-yl)-n-[(4-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC(C=2CC(ON=2)C2CCCCC2)=NC(C)=N1 UPCUZOMSXKDEHA-UHFFFAOYSA-N 0.000 claims 2
- BSUOXCWNKFVSGN-JOCHJYFZSA-N 6-[(5r)-5-(1-cyclopropyl-6-oxopyridazin-3-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@@H](ON=2)C2=NN(C(=O)C=C2)C2CC2)=C1 BSUOXCWNKFVSGN-JOCHJYFZSA-N 0.000 claims 2
- KHBLMURYLWZVDR-QFIPXVFZSA-N 6-[(5s)-5-(1-cyclopropyl-6-oxopyridin-3-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@H](ON=2)C2=CN(C(=O)C=C2)C2CC2)=C1 KHBLMURYLWZVDR-QFIPXVFZSA-N 0.000 claims 2
- OPDVFTMQUKTRKY-KBJGYGKASA-N 6-[(5s)-5-[(2r,5r)-5-(acetamidomethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(3-chloro-4-fluorophenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1O[C@H](CNC(=O)C)CO[C@H]1[C@H]1ON=C(C=2N=C(C)N=C(C=2)C(=O)NCC=2C=C(Cl)C(F)=CC=2)C1 OPDVFTMQUKTRKY-KBJGYGKASA-N 0.000 claims 2
- UDHYUGQMJBTKLS-UZFJHSOTSA-N 6-[(5s)-5-[(2r,5r)-5-(acetamidomethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@H](ON=2)[C@@H]2OC[C@@H](CNC(C)=O)OC2)=C1 UDHYUGQMJBTKLS-UZFJHSOTSA-N 0.000 claims 2
- NGJASFSHNCVYCP-MQNAVGNWSA-N 6-[(5s)-5-[(2r,5r)-5-(acetamidomethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methylphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1O[C@H](CNC(=O)C)CO[C@H]1[C@H]1ON=C(C=2N=C(C)N=C(C=2)C(=O)NCC=2C=C(C)C(F)=CC=2)C1 NGJASFSHNCVYCP-MQNAVGNWSA-N 0.000 claims 2
- QNCKHTIYGBLLDT-UZFJHSOTSA-N 6-[(5s)-5-[(2r,5r)-5-[(dimethylcarbamoylamino)methyl]-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@H](ON=2)[C@@H]2OC[C@@H](CNC(=O)N(C)C)OC2)=C1 QNCKHTIYGBLLDT-UZFJHSOTSA-N 0.000 claims 2
- UZLVHEAEQBVOHA-UZFJHSOTSA-N 6-[(5s)-5-[(2r,5r)-5-[[(2-cyanoacetyl)amino]methyl]-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@H](ON=2)[C@@H]2OC[C@@H](CNC(=O)CC#N)OC2)=C1 UZLVHEAEQBVOHA-UZFJHSOTSA-N 0.000 claims 2
- WUUFRYFCEHCEQV-ZCNNSNEGSA-N 6-[(5s)-5-[(2r,5s)-5-carbamoyl-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@H](ON=2)[C@@H]2OC[C@H](OC2)C(N)=O)=C1 WUUFRYFCEHCEQV-ZCNNSNEGSA-N 0.000 claims 2
- KHBLMURYLWZVDR-UHFFFAOYSA-N 6-[5-(1-cyclopropyl-6-oxopyridin-3-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2=CN(C(=O)C=C2)C2CC2)=C1 KHBLMURYLWZVDR-UHFFFAOYSA-N 0.000 claims 2
- VZTBAFBSCXVKCE-UHFFFAOYSA-N 6-[5-(6-cyanopyridazin-3-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(3,4-difluorophenyl)methyl]-2-methylpyrimidine-4-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.N=1C(C)=NC(C(=O)NCC=2C=C(F)C(F)=CC=2)=CC=1C(C1)=NOC1C1=CC=C(C#N)N=N1 VZTBAFBSCXVKCE-UHFFFAOYSA-N 0.000 claims 2
- MIMNGOFKWLSVIZ-UHFFFAOYSA-N 6-[5-(6-cyanopyridazin-3-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methylphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound N=1C(C)=NC(C(=O)NCC=2C=C(C)C(F)=CC=2)=CC=1C(C1)=NOC1C1=CC=C(C#N)N=N1 MIMNGOFKWLSVIZ-UHFFFAOYSA-N 0.000 claims 2
- QETOABANHONNPR-UHFFFAOYSA-N 6-[5-(6-cyanopyridazin-3-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluorophenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound N=1C(C)=NC(C(=O)NCC=2C=CC(F)=CC=2)=CC=1C(C1)=NOC1C1=CC=C(C#N)N=N1 QETOABANHONNPR-UHFFFAOYSA-N 0.000 claims 2
- ZEHSQVFSYSGUMS-UHFFFAOYSA-N 6-[5-[1-(2-acetamidoacetyl)piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)C(=O)CNC(C)=O)=C1 ZEHSQVFSYSGUMS-UHFFFAOYSA-N 0.000 claims 2
- BGBRJHULRSRLSU-UHFFFAOYSA-N 6-[5-[1-(2-cyanoacetyl)piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)C(=O)CC#N)=C1 BGBRJHULRSRLSU-UHFFFAOYSA-N 0.000 claims 2
- MFBQCYAYAPGPCB-UHFFFAOYSA-N 6-[5-[1-(cyclopropanecarbonyl)piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)C(=O)C2CC2)=C1 MFBQCYAYAPGPCB-UHFFFAOYSA-N 0.000 claims 2
- XQNBHDOKYLYLNK-UHFFFAOYSA-N 6-[5-[1-(ethylcarbamoyl)piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1CN(C(=O)NCC)CCC1C1ON=C(C=2N=C(C)N=C(C=2)C(=O)NCC=2C=C(OC)C(F)=CC=2)C1 XQNBHDOKYLYLNK-UHFFFAOYSA-N 0.000 claims 2
- WYNDXPACGFLUGD-UHFFFAOYSA-N 6-[5-[1-[2-(cyclopropylamino)-2-oxoethyl]-6-oxopyridin-3-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2=CN(CC(=O)NC3CC3)C(=O)C=C2)=C1 WYNDXPACGFLUGD-UHFFFAOYSA-N 0.000 claims 2
- QVKBAQDUWARSNI-UHFFFAOYSA-N 6-[5-[5-chloro-1-[2-(methylamino)-2-oxoethyl]-6-oxopyridin-3-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(Cl)C(=O)N(CC(=O)NC)C=C1C1ON=C(C=2N=C(C)N=C(C=2)C(=O)NCC=2C=C(OC)C(F)=CC=2)C1 QVKBAQDUWARSNI-UHFFFAOYSA-N 0.000 claims 2
- JOXMIWKXJWNRTP-ZTBHGZPVSA-N O[C@H](C(=O)NC1CCC(CC1)C1C(=NOC1)C=1C(=NC(=NC=1)C)C(=O)N)C Chemical compound O[C@H](C(=O)NC1CCC(CC1)C1C(=NOC1)C=1C(=NC(=NC=1)C)C(=O)N)C JOXMIWKXJWNRTP-ZTBHGZPVSA-N 0.000 claims 2
- 125000006392 alkylpyrimidinyl group Chemical group 0.000 claims 2
- 125000004429 atom Chemical group 0.000 claims 2
- 125000002785 azepinyl group Chemical group 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 2
- 125000004122 cyclic group Chemical group 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 150000004677 hydrates Chemical class 0.000 claims 2
- 125000004857 imidazopyridinyl group Chemical group N1C(=NC2=C1C=CC=N2)* 0.000 claims 2
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 claims 2
- 125000004594 isoindolinyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 claims 2
- 239000002207 metabolite Substances 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- ZLTRUCOVZUWPBM-UJUVCNOISA-N n-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-6-[(5r)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@@H]1[C@@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=C3OCCOC3=CC=2)O[C@H](CO)CO1 ZLTRUCOVZUWPBM-UJUVCNOISA-N 0.000 claims 2
- ZLTRUCOVZUWPBM-KBJGYGKASA-N n-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-6-[(5s)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@@H]1[C@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=C3OCCOC3=CC=2)O[C@H](CO)CO1 ZLTRUCOVZUWPBM-KBJGYGKASA-N 0.000 claims 2
- KPQDSKFVSZMAJO-URZJWIJPSA-N n-(2,3-dihydro-1-benzofuran-5-ylmethyl)-6-[(5s)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@@H]1[C@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=C3CCOC3=CC=2)O[C@H](CO)CO1 KPQDSKFVSZMAJO-URZJWIJPSA-N 0.000 claims 2
- WPRXUJFABHKJIO-SMHULIPUSA-N n-[(3,4-dichlorophenyl)methyl]-6-[(5r)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@@H]1[C@@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=C(Cl)C(Cl)=CC=2)O[C@H](CO)CO1 WPRXUJFABHKJIO-SMHULIPUSA-N 0.000 claims 2
- NZNCGDUQFWKCEB-SMHULIPUSA-N n-[(3,4-difluorophenyl)methyl]-6-[(5r)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@@H]1[C@@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=C(F)C(F)=CC=2)O[C@H](CO)CO1 NZNCGDUQFWKCEB-SMHULIPUSA-N 0.000 claims 2
- NZNCGDUQFWKCEB-CAYVGHNUSA-N n-[(3,4-difluorophenyl)methyl]-6-[(5s)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@@H]1[C@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=C(F)C(F)=CC=2)O[C@H](CO)CO1 NZNCGDUQFWKCEB-CAYVGHNUSA-N 0.000 claims 2
- POCGPTVKWWVDHU-SMHULIPUSA-N n-[(3-chloro-4-fluorophenyl)methyl]-6-[(5r)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@@H]1[C@@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=C(Cl)C(F)=CC=2)O[C@H](CO)CO1 POCGPTVKWWVDHU-SMHULIPUSA-N 0.000 claims 2
- ZSOZNSMQLIIHBO-UHFFFAOYSA-N n-[(3-chloro-4-fluorophenyl)methyl]-6-[5-(6-cyanopyridazin-3-yl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound N=1C(C)=NC(C(=O)NCC=2C=C(Cl)C(F)=CC=2)=CC=1C(C1)=NOC1C1=CC=C(C#N)N=N1 ZSOZNSMQLIIHBO-UHFFFAOYSA-N 0.000 claims 2
- NFMUXCPSAQLIPX-CDHQVMDDSA-N n-[(3-fluorophenyl)methyl]-6-[(5r)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@@H]1[C@@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=C(F)C=CC=2)O[C@H](CO)CO1 NFMUXCPSAQLIPX-CDHQVMDDSA-N 0.000 claims 2
- NFMUXCPSAQLIPX-UIAACRFSSA-N n-[(3-fluorophenyl)methyl]-6-[(5s)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@@H]1[C@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=C(F)C=CC=2)O[C@H](CO)CO1 NFMUXCPSAQLIPX-UIAACRFSSA-N 0.000 claims 2
- NJONGVJOBWDJFQ-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methyl-6-(5-pyridin-3-yl-4,5-dihydro-1h-pyrazol-3-yl)pyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(NN=2)C=2C=NC=CC=2)=C1 NJONGVJOBWDJFQ-UHFFFAOYSA-N 0.000 claims 2
- CRMHCCJNEYVRPY-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methyl-6-[5-[6-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]pyridin-3-yl]-4,5-dihydro-1,2-oxazol-3-yl]pyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2=CN(CC(=O)NC(C)C)C(=O)C=C2)=C1 CRMHCCJNEYVRPY-UHFFFAOYSA-N 0.000 claims 2
- MYYHERXNVLQLPV-UJUVCNOISA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[(5r)-5-[(2r,5r)-5-(methoxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1O[C@H](COC)CO[C@H]1[C@@H]1ON=C(C=2N=C(C)N=C(C=2)C(=O)NCC=2C=C(OC)C(F)=CC=2)C1 MYYHERXNVLQLPV-UJUVCNOISA-N 0.000 claims 2
- VUMINWLDNHKRNZ-DLPLYFIVSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[(5r)-5-[(2s,5s)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@@H](ON=2)[C@H]2OC[C@H](CO)OC2)=C1 VUMINWLDNHKRNZ-DLPLYFIVSA-N 0.000 claims 2
- MYYHERXNVLQLPV-KBJGYGKASA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[(5s)-5-[(2r,5r)-5-(methoxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1O[C@H](COC)CO[C@H]1[C@H]1ON=C(C=2N=C(C)N=C(C=2)C(=O)NCC=2C=C(OC)C(F)=CC=2)C1 MYYHERXNVLQLPV-KBJGYGKASA-N 0.000 claims 2
- HUBSMBFUBXCXEA-UZFJHSOTSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[(5s)-5-[(2r,5r)-5-[[(2-hydroxy-2-methylpropanoyl)amino]methyl]-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@H](ON=2)[C@@H]2OC[C@@H](CNC(=O)C(C)(C)O)OC2)=C1 HUBSMBFUBXCXEA-UZFJHSOTSA-N 0.000 claims 2
- UIDMPBQFXUBJBM-BDTNDASRSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[(5s)-5-[(2r,5s)-5-(2-hydroxypropan-2-yl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@H](ON=2)[C@@H]2OC[C@H](OC2)C(C)(C)O)=C1 UIDMPBQFXUBJBM-BDTNDASRSA-N 0.000 claims 2
- SSORJRCSPSSGJH-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[5-[1-(2-hydroxyethyl)-6-oxopyridin-3-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2=CN(CCO)C(=O)C=C2)=C1 SSORJRCSPSSGJH-UHFFFAOYSA-N 0.000 claims 2
- GRCFFZIUCALRRH-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[5-[1-(2-hydroxyethylcarbamoyl)piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)C(=O)NCCO)=C1 GRCFFZIUCALRRH-UHFFFAOYSA-N 0.000 claims 2
- IWQHLJXMUPIVSX-IPHXSNPTSA-N n-[(4-fluoro-3-methylphenyl)methyl]-6-[(5r)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@@H]1[C@@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=C(C)C(F)=CC=2)O[C@H](CO)CO1 IWQHLJXMUPIVSX-IPHXSNPTSA-N 0.000 claims 2
- CDVGIXMNPDEFMY-CDHQVMDDSA-N n-[(4-fluorophenyl)methyl]-6-[(5r)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@@H]1[C@@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=CC(F)=CC=2)O[C@H](CO)CO1 CDVGIXMNPDEFMY-CDHQVMDDSA-N 0.000 claims 2
- CDVGIXMNPDEFMY-UIAACRFSSA-N n-[(4-fluorophenyl)methyl]-6-[(5s)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@@H]1[C@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=CC(F)=CC=2)O[C@H](CO)CO1 CDVGIXMNPDEFMY-UIAACRFSSA-N 0.000 claims 2
- 201000008482 osteoarthritis Diseases 0.000 claims 2
- 239000000651 prodrug Substances 0.000 claims 2
- 229940002612 prodrug Drugs 0.000 claims 2
- 125000004621 quinuclidinyl group Chemical group N12C(CC(CC1)CC2)* 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- 125000003107 substituted aryl group Chemical group 0.000 claims 2
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims 2
- 125000005888 tetrahydroindolyl group Chemical group 0.000 claims 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims 2
- DVVGIUUJYPYENY-UHFFFAOYSA-N 1-methylpyridin-2-one Chemical compound CN1C=CC=CC1=O DVVGIUUJYPYENY-UHFFFAOYSA-N 0.000 claims 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims 1
- PKMYPARGAZZRPU-UHFFFAOYSA-N 3-[6-[(4-fluoro-3-methoxyphenyl)methylcarbamoyl]-2-methylpyrimidin-4-yl]-4,5-dihydro-1,2-oxazole-5-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C(N)=O)=C1 PKMYPARGAZZRPU-UHFFFAOYSA-N 0.000 claims 1
- HSIFWXRIRBCVSN-UHFFFAOYSA-N 3-[6-[(4-fluoro-3-methoxyphenyl)methylcarbamoyl]-2-methylpyrimidin-4-yl]-n-(2-hydroxyethyl)-4,5-dihydro-1,2-oxazole-5-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C(=O)NCCO)=C1 HSIFWXRIRBCVSN-UHFFFAOYSA-N 0.000 claims 1
- QUKFOEYYERLLHD-UHFFFAOYSA-N 4-[3-[2-[(3-methoxyphenyl)methylcarbamoyl]pyridin-4-yl]-4,5-dihydro-1,2-oxazol-5-yl]benzoic acid Chemical compound COC1=CC=CC(CNC(=O)C=2N=CC=C(C=2)C=2CC(ON=2)C=2C=CC(=CC=2)C(O)=O)=C1 QUKFOEYYERLLHD-UHFFFAOYSA-N 0.000 claims 1
- FUUJBNDEKUZXDE-UHFFFAOYSA-N 4-[3-[2-[(4-methoxyphenyl)methylcarbamoyl]pyridin-4-yl]-4,5-dihydro-1,2-oxazol-5-yl]benzoic acid Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC(C=2CC(ON=2)C=2C=CC(=CC=2)C(O)=O)=CC=N1 FUUJBNDEKUZXDE-UHFFFAOYSA-N 0.000 claims 1
- YEYDUPQIDIQSMF-UHFFFAOYSA-N 6-(5-cyano-4,5-dihydro-1,2-oxazol-3-yl)-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C#N)=C1 YEYDUPQIDIQSMF-UHFFFAOYSA-N 0.000 claims 1
- KIHSELXDJPJAOY-UHFFFAOYSA-N 6-(5-cyclohexyl-4,5-dihydro-1,2-oxazol-3-yl)-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCCCC2)=C1 KIHSELXDJPJAOY-UHFFFAOYSA-N 0.000 claims 1
- KHBLMURYLWZVDR-JOCHJYFZSA-N 6-[(5r)-5-(1-cyclopropyl-6-oxopyridin-3-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@@H](ON=2)C2=CN(C(=O)C=C2)C2CC2)=C1 KHBLMURYLWZVDR-JOCHJYFZSA-N 0.000 claims 1
- UBIRUTGOXKERES-MAODMQOUSA-N 6-[(5r)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC(C=2C[C@@H](ON=2)[C@@H]2OC[C@@H](CO)OC2)=NC(C)=N1 UBIRUTGOXKERES-MAODMQOUSA-N 0.000 claims 1
- FBHBZYVPGXBFMY-DQLDELGASA-N 6-[(5r)-5-[(2s,5s)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound COC1=CC=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@@H](ON=2)[C@H]2OC[C@H](CO)OC2)=C1 FBHBZYVPGXBFMY-DQLDELGASA-N 0.000 claims 1
- UBIRUTGOXKERES-DQLDELGASA-N 6-[(5r)-5-[(2s,5s)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC(C=2C[C@@H](ON=2)[C@H]2OC[C@H](CO)OC2)=NC(C)=N1 UBIRUTGOXKERES-DQLDELGASA-N 0.000 claims 1
- LQVNBOCRYMDTLX-KBJGYGKASA-N 6-[(5s)-5-[(2r,5r)-5-(cyanomethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@H](ON=2)[C@@H]2OC[C@@H](CC#N)OC2)=C1 LQVNBOCRYMDTLX-KBJGYGKASA-N 0.000 claims 1
- FBHBZYVPGXBFMY-TYCQWZJGSA-N 6-[(5s)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound COC1=CC=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@H](ON=2)[C@@H]2OC[C@@H](CO)OC2)=C1 FBHBZYVPGXBFMY-TYCQWZJGSA-N 0.000 claims 1
- UBIRUTGOXKERES-TYCQWZJGSA-N 6-[(5s)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC(C=2C[C@H](ON=2)[C@@H]2OC[C@@H](CO)OC2)=NC(C)=N1 UBIRUTGOXKERES-TYCQWZJGSA-N 0.000 claims 1
- FBHBZYVPGXBFMY-NDXORKPFSA-N 6-[(5s)-5-[(2s,5s)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound COC1=CC=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@H](ON=2)[C@H]2OC[C@H](CO)OC2)=C1 FBHBZYVPGXBFMY-NDXORKPFSA-N 0.000 claims 1
- UBIRUTGOXKERES-NDXORKPFSA-N 6-[(5s)-5-[(2s,5s)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC(C=2C[C@H](ON=2)[C@H]2OC[C@H](CO)OC2)=NC(C)=N1 UBIRUTGOXKERES-NDXORKPFSA-N 0.000 claims 1
- YNCUASCNSKFXMT-UHFFFAOYSA-N 6-[3-[4-(2-hydroxyethoxy)phenyl]-4,5-dihydro-1,2-oxazol-5-yl]-n-[(4-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=CC(OC)=CC=C1CNC(=O)C1=CC(C2ON=C(C2)C=2C=CC(OCCO)=CC=2)=NC(C)=N1 YNCUASCNSKFXMT-UHFFFAOYSA-N 0.000 claims 1
- ABUXLUNBTKCHMK-UHFFFAOYSA-N 6-[5-(1-acetylpiperidin-4-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(3,4-difluorophenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1CN(C(=O)C)CCC1C1ON=C(C=2N=C(C)N=C(C=2)C(=O)NCC=2C=C(F)C(F)=CC=2)C1 ABUXLUNBTKCHMK-UHFFFAOYSA-N 0.000 claims 1
- YMPRAPBOGNDAMB-UHFFFAOYSA-N 6-[5-(1-acetylpiperidin-4-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(3-chloro-4-fluorophenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1CN(C(=O)C)CCC1C1ON=C(C=2N=C(C)N=C(C=2)C(=O)NCC=2C=C(Cl)C(F)=CC=2)C1 YMPRAPBOGNDAMB-UHFFFAOYSA-N 0.000 claims 1
- VMIMWYZCKROPHO-UHFFFAOYSA-N 6-[5-(1-acetylpiperidin-4-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound COC1=CC=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)C(C)=O)=C1 VMIMWYZCKROPHO-UHFFFAOYSA-N 0.000 claims 1
- OCDKNHLPRQKXSM-UHFFFAOYSA-N 6-[5-(1-acetylpiperidin-4-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)C(C)=O)=C1 OCDKNHLPRQKXSM-UHFFFAOYSA-N 0.000 claims 1
- BZKGWGRWLCPLCT-UHFFFAOYSA-N 6-[5-(1-acetylpiperidin-4-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methylphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1CN(C(=O)C)CCC1C1ON=C(C=2N=C(C)N=C(C=2)C(=O)NCC=2C=C(C)C(F)=CC=2)C1 BZKGWGRWLCPLCT-UHFFFAOYSA-N 0.000 claims 1
- BCNZDERMXCGBAG-UHFFFAOYSA-N 6-[5-(1-acetylpiperidin-4-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluorophenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1CN(C(=O)C)CCC1C1ON=C(C=2N=C(C)N=C(C=2)C(=O)NCC=2C=CC(F)=CC=2)C1 BCNZDERMXCGBAG-UHFFFAOYSA-N 0.000 claims 1
- IMIWNHDFOKMDEV-UHFFFAOYSA-N 6-[5-(1-acetylpiperidin-4-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC(C=2CC(ON=2)C2CCN(CC2)C(C)=O)=NC(C)=N1 IMIWNHDFOKMDEV-UHFFFAOYSA-N 0.000 claims 1
- BSUOXCWNKFVSGN-UHFFFAOYSA-N 6-[5-(1-cyclopropyl-6-oxopyridazin-3-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2=NN(C(=O)C=C2)C2CC2)=C1 BSUOXCWNKFVSGN-UHFFFAOYSA-N 0.000 claims 1
- HFZLZQLYMOWBMA-UHFFFAOYSA-N 6-[5-(1-cyclopropylsulfonylpiperidin-4-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)S(=O)(=O)C2CC2)=C1 HFZLZQLYMOWBMA-UHFFFAOYSA-N 0.000 claims 1
- TUDAPIPJLPXVSX-UHFFFAOYSA-N 6-[5-(1-ethylsulfonylpiperidin-4-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1CN(S(=O)(=O)CC)CCC1C1ON=C(C=2N=C(C)N=C(C=2)C(=O)NCC=2C=C(OC)C(F)=CC=2)C1 TUDAPIPJLPXVSX-UHFFFAOYSA-N 0.000 claims 1
- UOXQXLLIMOYXAT-UHFFFAOYSA-N 6-[5-(2-carbamoylpyridin-4-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C=2C=C(N=CC=2)C(N)=O)=C1 UOXQXLLIMOYXAT-UHFFFAOYSA-N 0.000 claims 1
- QIQWUPWKRUDLNC-UHFFFAOYSA-N 6-[5-(3-carbamoylphenyl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C=2C=C(C=CC=2)C(N)=O)=C1 QIQWUPWKRUDLNC-UHFFFAOYSA-N 0.000 claims 1
- QZFVQZANCFRQMP-UHFFFAOYSA-N 6-[5-(4-carbamoylphenyl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C=2C=CC(=CC=2)C(N)=O)=C1 QZFVQZANCFRQMP-UHFFFAOYSA-N 0.000 claims 1
- DWZUMKXSEWDFCI-UHFFFAOYSA-N 6-[5-(4-carbamoylphenyl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC(C=2CC(ON=2)C=2C=CC(=CC=2)C(N)=O)=NC(C)=N1 DWZUMKXSEWDFCI-UHFFFAOYSA-N 0.000 claims 1
- JKNBTFSEKUNTHE-UHFFFAOYSA-N 6-[5-(4-methoxyphenyl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC(C=2CC(ON=2)C=2C=CC(OC)=CC=2)=NC(C)=N1 JKNBTFSEKUNTHE-UHFFFAOYSA-N 0.000 claims 1
- DLQIWQIRMNSNGU-UHFFFAOYSA-N 6-[5-(5-acetylpyridin-2-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C=2N=CC(=CC=2)C(C)=O)=C1 DLQIWQIRMNSNGU-UHFFFAOYSA-N 0.000 claims 1
- BBZOBIVRJKEVKD-UHFFFAOYSA-N 6-[5-(5-carbamoyl-2-methylpyrazol-3-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C=2N(N=C(C=2)C(N)=O)C)=C1 BBZOBIVRJKEVKD-UHFFFAOYSA-N 0.000 claims 1
- QTKSHIASVPMECN-UHFFFAOYSA-N 6-[5-(5-cyanopyridin-2-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C=2N=CC(=CC=2)C#N)=C1 QTKSHIASVPMECN-UHFFFAOYSA-N 0.000 claims 1
- IZIQZKUMHFLYHL-UHFFFAOYSA-N 6-[5-(6-cyanopyridazin-3-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C=2N=NC(=CC=2)C#N)=C1 IZIQZKUMHFLYHL-UHFFFAOYSA-N 0.000 claims 1
- YSIHNPGXCFXGAO-UHFFFAOYSA-N 6-[5-(6-cyanopyridin-3-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C=2C=NC(=CC=2)C#N)=C1 YSIHNPGXCFXGAO-UHFFFAOYSA-N 0.000 claims 1
- DKAATJPTQGKKPT-UHFFFAOYSA-N 6-[5-(bromomethyl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(CBr)ON=2)=C1 DKAATJPTQGKKPT-UHFFFAOYSA-N 0.000 claims 1
- GWZCVMZPNCJAHM-UHFFFAOYSA-N 6-[5-[(1-acetylpiperidin-4-yl)methyl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(CC3CCN(CC3)C(C)=O)ON=2)=C1 GWZCVMZPNCJAHM-UHFFFAOYSA-N 0.000 claims 1
- FBHBZYVPGXBFMY-PMYDAVCKSA-N 6-[5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound COC1=CC=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)[C@@H]2OC[C@@H](CO)OC2)=C1 FBHBZYVPGXBFMY-PMYDAVCKSA-N 0.000 claims 1
- BDOLFGRFWDZWQK-UHFFFAOYSA-N 6-[5-[(4-acetylpiperazin-1-yl)methyl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(CN3CCN(CC3)C(C)=O)ON=2)=C1 BDOLFGRFWDZWQK-UHFFFAOYSA-N 0.000 claims 1
- UPOLDGMCGLSOPT-UHFFFAOYSA-N 6-[5-[1-(1,2-dimethylimidazol-4-yl)sulfonylpiperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)S(=O)(=O)C=2N=C(C)N(C)C=2)=C1 UPOLDGMCGLSOPT-UHFFFAOYSA-N 0.000 claims 1
- IOOZZRLZGLMCDB-UHFFFAOYSA-N 6-[5-[1-(2-hydroxyacetyl)piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound COC1=CC=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)C(=O)CO)=C1 IOOZZRLZGLMCDB-UHFFFAOYSA-N 0.000 claims 1
- TYYNEHSCVIZISN-UHFFFAOYSA-N 6-[5-[1-(cyclobutanecarbonyl)piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)C(=O)C2CCC2)=C1 TYYNEHSCVIZISN-UHFFFAOYSA-N 0.000 claims 1
- VMYCKPMBUIXAEQ-UHFFFAOYSA-N 6-[5-[1-(dimethylcarbamoyl)piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)C(=O)N(C)C)=C1 VMYCKPMBUIXAEQ-UHFFFAOYSA-N 0.000 claims 1
- LVNYZRAMRUBUKL-UHFFFAOYSA-N 6-[5-[1-[(3,5-dimethyl-1,2-oxazol-4-yl)sulfonyl]piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)S(=O)(=O)C2=C(ON=C2C)C)=C1 LVNYZRAMRUBUKL-UHFFFAOYSA-N 0.000 claims 1
- CJFYPZINDJIFND-UHFFFAOYSA-N 6-[5-[1-[2-(dimethylamino)-2-oxoethyl]-2-oxopyridin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2=CC(=O)N(CC(=O)N(C)C)C=C2)=C1 CJFYPZINDJIFND-UHFFFAOYSA-N 0.000 claims 1
- KUSVSYIDZUCJSF-UHFFFAOYSA-N 6-[5-[1-[2-(dimethylamino)acetyl]piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)C(=O)CN(C)C)=C1 KUSVSYIDZUCJSF-UHFFFAOYSA-N 0.000 claims 1
- JLPVTKZIJFLXMA-UHFFFAOYSA-N 6-[5-[1-[3-(dimethylamino)propanoyl]piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)C(=O)CCN(C)C)=C1 JLPVTKZIJFLXMA-UHFFFAOYSA-N 0.000 claims 1
- DJQPQHURFAAVGN-UHFFFAOYSA-N 6-[5-[3-(2-hydroxyethoxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC(C=2CC(ON=2)C=2C=C(OCCO)C=CC=2)=NC(C)=N1 DJQPQHURFAAVGN-UHFFFAOYSA-N 0.000 claims 1
- IYLGFEORMHWKGV-UHFFFAOYSA-N 6-[5-[4-(2-hydroxyethoxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC(C=2CC(ON=2)C=2C=CC(OCCO)=CC=2)=NC(C)=N1 IYLGFEORMHWKGV-UHFFFAOYSA-N 0.000 claims 1
- PSUBTMAPVXCDPK-UHFFFAOYSA-N 6-[5-[4-(2-hydroxyethoxy)phenyl]-5-methyl-4h-1,2-oxazol-3-yl]-n-[(4-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=CC(OC)=CC=C1CNC(=O)C1=CC(C=2CC(C)(ON=2)C=2C=CC(OCCO)=CC=2)=NC(C)=N1 PSUBTMAPVXCDPK-UHFFFAOYSA-N 0.000 claims 1
- CYFFMARQRZWDLL-UHFFFAOYSA-N 6-[5-[4-(dimethylamino)phenyl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC(C=2CC(ON=2)C=2C=CC(=CC=2)N(C)C)=NC(C)=N1 CYFFMARQRZWDLL-UHFFFAOYSA-N 0.000 claims 1
- DTZCBHGHKXIGNI-UHFFFAOYSA-N 6-[5-[4-(hydroxymethyl)phenyl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC(C=2CC(ON=2)C=2C=CC(CO)=CC=2)=NC(C)=N1 DTZCBHGHKXIGNI-UHFFFAOYSA-N 0.000 claims 1
- IKSXVZQIJQZEEI-UHFFFAOYSA-N 6-[5-[4-(hydroxymethyl)phenyl]-5-methyl-4h-1,2-oxazol-3-yl]-n-[(4-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC(C=2CC(C)(ON=2)C=2C=CC(CO)=CC=2)=NC(C)=N1 IKSXVZQIJQZEEI-UHFFFAOYSA-N 0.000 claims 1
- KOSVWFMXGQDBEG-UHFFFAOYSA-N 6-[5-[6-(dimethylamino)pyridazin-3-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C=2N=NC(=CC=2)N(C)C)=C1 KOSVWFMXGQDBEG-UHFFFAOYSA-N 0.000 claims 1
- SZPWBEHOJDLULG-UHFFFAOYSA-N CC1=NC=C(C(C2)=NOC2C(C=CN2C3CC3)=CC2=O)C(C(NCC(C=C2)=CC(OC)=C2F)=O)=N1 Chemical compound CC1=NC=C(C(C2)=NOC2C(C=CN2C3CC3)=CC2=O)C(C(NCC(C=C2)=CC(OC)=C2F)=O)=N1 SZPWBEHOJDLULG-UHFFFAOYSA-N 0.000 claims 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims 1
- 208000003456 Juvenile Arthritis Diseases 0.000 claims 1
- 206010059176 Juvenile idiopathic arthritis Diseases 0.000 claims 1
- GRKWOBDTMOXZDO-UHFFFAOYSA-N N1=C(C=CC=C1)C(=O)NC1=NOC(C1)C1=CC=C(C=C1)OC Chemical compound N1=C(C=CC=C1)C(=O)NC1=NOC(C1)C1=CC=C(C=C1)OC GRKWOBDTMOXZDO-UHFFFAOYSA-N 0.000 claims 1
- JKBBPBQSMCPUHV-UHFFFAOYSA-N N1=CN=C(C=C1)C(=O)NC1=NOC(C1)C1CCN(CC1)S(=O)(=O)CCC Chemical compound N1=CN=C(C=C1)C(=O)NC1=NOC(C1)C1CCN(CC1)S(=O)(=O)CCC JKBBPBQSMCPUHV-UHFFFAOYSA-N 0.000 claims 1
- 201000001263 Psoriatic Arthritis Diseases 0.000 claims 1
- 208000036824 Psoriatic arthropathy Diseases 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 claims 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims 1
- 230000000975 bioactive effect Effects 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- QFUANYPJSKONLS-UHFFFAOYSA-N methyl 3-[6-[(4-fluoro-3-methoxyphenyl)methylcarbamoyl]-2-methylpyrimidin-4-yl]-4,5-dihydro-1,2-oxazole-5-carboxylate Chemical compound O1C(C(=O)OC)CC(C=2N=C(C)N=C(C=2)C(=O)NCC=2C=C(OC)C(F)=CC=2)=N1 QFUANYPJSKONLS-UHFFFAOYSA-N 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 125000004312 morpholin-2-yl group Chemical group [H]N1C([H])([H])C([H])([H])OC([H])(*)C1([H])[H] 0.000 claims 1
- WPRXUJFABHKJIO-CAYVGHNUSA-N n-[(3,4-dichlorophenyl)methyl]-6-[(5s)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@@H]1[C@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=C(Cl)C(Cl)=CC=2)O[C@H](CO)CO1 WPRXUJFABHKJIO-CAYVGHNUSA-N 0.000 claims 1
- PNMSJCNGUJWZSY-UHFFFAOYSA-N n-[(3,4-difluorophenyl)methyl]-6-[5-[1-(2-hydroxyacetyl)piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound N=1C(C)=NC(C(=O)NCC=2C=C(F)C(F)=CC=2)=CC=1C(C1)=NOC1C1CCN(C(=O)CO)CC1 PNMSJCNGUJWZSY-UHFFFAOYSA-N 0.000 claims 1
- POCGPTVKWWVDHU-SVIJTADQSA-N n-[(3-chloro-4-fluorophenyl)methyl]-6-[(5r)-5-[(2s,5s)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@H]1[C@@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=C(Cl)C(F)=CC=2)O[C@@H](CO)CO1 POCGPTVKWWVDHU-SVIJTADQSA-N 0.000 claims 1
- POCGPTVKWWVDHU-MRFFXTKBSA-N n-[(3-chloro-4-fluorophenyl)methyl]-6-[(5s)-5-[(2s,5s)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@H]1[C@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=C(Cl)C(F)=CC=2)O[C@@H](CO)CO1 POCGPTVKWWVDHU-MRFFXTKBSA-N 0.000 claims 1
- CWNRJENDTYRZPH-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-1-methyl-6-oxo-5-(5-phenyl-4,5-dihydro-1,2-oxazol-3-yl)pyridazine-3-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C2=NN(C)C(=O)C(C=3CC(ON=3)C=3C=CC=CC=3)=C2)=C1 CWNRJENDTYRZPH-UHFFFAOYSA-N 0.000 claims 1
- BXDCMUHKTBMPAZ-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methyl-6-(5-piperidin-4-yl-4,5-dihydro-1,2-oxazol-3-yl)pyrimidine-4-carboxamide;hydrochloride Chemical compound Cl.C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCNCC2)=C1 BXDCMUHKTBMPAZ-UHFFFAOYSA-N 0.000 claims 1
- ZSQFXGZBGLCCKV-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methyl-6-[5-(1-methylsulfonylpiperidin-4-yl)-4,5-dihydro-1,2-oxazol-3-yl]pyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)S(C)(=O)=O)=C1 ZSQFXGZBGLCCKV-UHFFFAOYSA-N 0.000 claims 1
- QXCILQPOFXCONT-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methyl-6-[5-(1-propan-2-ylsulfonylpiperidin-4-yl)-4,5-dihydro-1,2-oxazol-3-yl]pyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)S(=O)(=O)C(C)C)=C1 QXCILQPOFXCONT-UHFFFAOYSA-N 0.000 claims 1
- LPELAXBWOYQRGR-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methyl-6-[5-(1h-pyrazol-4-yl)-4,5-dihydro-1,2-oxazol-3-yl]pyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2=CNN=C2)=C1 LPELAXBWOYQRGR-UHFFFAOYSA-N 0.000 claims 1
- WHZUKRXYHUFFHD-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methyl-6-[5-(1h-pyrazolo[3,4-b]pyridin-5-yl)-4,5-dihydro-1,2-oxazol-3-yl]pyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C=2C=C3C=NNC3=NC=2)=C1 WHZUKRXYHUFFHD-UHFFFAOYSA-N 0.000 claims 1
- ZGULZVKQCWADOX-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methyl-6-[5-(2h-tetrazol-5-yl)-4,5-dihydro-1,2-oxazol-3-yl]pyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2=NNN=N2)=C1 ZGULZVKQCWADOX-UHFFFAOYSA-N 0.000 claims 1
- AVLTXGCYJSINCV-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methyl-6-[5-(6-oxo-1-propan-2-ylpyridin-3-yl)-4,5-dihydro-1,2-oxazol-3-yl]pyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2=CN(C(=O)C=C2)C(C)C)=C1 AVLTXGCYJSINCV-UHFFFAOYSA-N 0.000 claims 1
- BKGRYZLVDRTDQV-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methyl-6-[5-[1-(1,2-oxazol-3-ylcarbamoyl)piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]pyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)C(=O)NC2=NOC=C2)=C1 BKGRYZLVDRTDQV-UHFFFAOYSA-N 0.000 claims 1
- WZVDBIOGJCLMLB-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methyl-6-[5-[1-(methylcarbamoyl)piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]pyrimidine-4-carboxamide Chemical compound C1CN(C(=O)NC)CCC1C1ON=C(C=2N=C(C)N=C(C=2)C(=O)NCC=2C=C(OC)C(F)=CC=2)C1 WZVDBIOGJCLMLB-UHFFFAOYSA-N 0.000 claims 1
- GNMHRHIBXLKJFV-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methyl-6-[5-[1-(propan-2-ylcarbamoyl)piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]pyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)C(=O)NC(C)C)=C1 GNMHRHIBXLKJFV-UHFFFAOYSA-N 0.000 claims 1
- UOXUDWLNTJLETM-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methyl-6-[5-[6-(methylcarbamoyl)pyridazin-3-yl]-4,5-dihydro-1,2-oxazol-3-yl]pyrimidine-4-carboxamide Chemical compound N1=NC(C(=O)NC)=CC=C1C1ON=C(C=2N=C(C)N=C(C=2)C(=O)NCC=2C=C(OC)C(F)=CC=2)C1 UOXUDWLNTJLETM-UHFFFAOYSA-N 0.000 claims 1
- QRTWNVYTNYIGHX-KBJGYGKASA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[(5s)-5-[(2r,5r)-5-[[(2-hydroxyacetyl)amino]methyl]-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@H](ON=2)[C@@H]2OC[C@@H](CNC(=O)CO)OC2)=C1 QRTWNVYTNYIGHX-KBJGYGKASA-N 0.000 claims 1
- LOIDEQYZUZFJCU-PHAMGYDHSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[(5s)-5-[(2r,5r)-5-[[[(2s)-2-hydroxypropanoyl]amino]methyl]-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@H](ON=2)[C@@H]2OC[C@@H](CNC(=O)[C@H](C)O)OC2)=C1 LOIDEQYZUZFJCU-PHAMGYDHSA-N 0.000 claims 1
- GZEVFPQEYSSLOA-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[3-[4-(2-hydroxyethoxy)phenyl]-4,5-dihydro-1,2-oxazol-5-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C2ON=C(C2)C=2C=CC(OCCO)=CC=2)=C1 GZEVFPQEYSSLOA-UHFFFAOYSA-N 0.000 claims 1
- VTRGFTVUYJYTRK-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[5-(1h-imidazol-5-yl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C=2N=CNC=2)=C1 VTRGFTVUYJYTRK-UHFFFAOYSA-N 0.000 claims 1
- XDESZNJZNUNRPA-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[5-(4-hydroxycyclohexyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCC(O)CC2)=C1 XDESZNJZNUNRPA-UHFFFAOYSA-N 0.000 claims 1
- HVUBKDBTMMRZID-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[5-[1-(1-methoxyethyl)-2-oxopyridin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound O=C1N(C(C)OC)C=CC(C2ON=C(C2)C=2N=C(C)N=C(C=2)C(=O)NCC=2C=C(OC)C(F)=CC=2)=C1 HVUBKDBTMMRZID-UHFFFAOYSA-N 0.000 claims 1
- XEVQTPDDBAWNMF-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[5-[1-(2-hydroxy-2-methylpropanoyl)piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)C(=O)C(C)(C)O)=C1 XEVQTPDDBAWNMF-UHFFFAOYSA-N 0.000 claims 1
- QVSDJBBXQLHZKR-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[5-[1-(2-hydroxyacetyl)piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)C(=O)CO)=C1 QVSDJBBXQLHZKR-UHFFFAOYSA-N 0.000 claims 1
- GJSIEEKUUHNEEL-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[5-[1-[2-hydroxyethyl(methyl)carbamoyl]piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)C(=O)N(C)CCO)=C1 GJSIEEKUUHNEEL-UHFFFAOYSA-N 0.000 claims 1
- VOTXJESWASBGSA-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[5-[2-(2-hydroxypropan-2-yl)pyridin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C=2C=C(N=CC=2)C(C)(C)O)=C1 VOTXJESWASBGSA-UHFFFAOYSA-N 0.000 claims 1
- LZEVBBPDPFANJA-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[5-[4-(hydroxymethyl)phenyl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C=2C=CC(CO)=CC=2)=C1 LZEVBBPDPFANJA-UHFFFAOYSA-N 0.000 claims 1
- OEZVJYXHTCCFRL-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[5-[4-[4-(hydroxymethyl)piperidin-1-yl]phenyl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C=2C=CC(=CC=2)N2CCC(CO)CC2)=C1 OEZVJYXHTCCFRL-UHFFFAOYSA-N 0.000 claims 1
- ATOKUWJNXHKBKF-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[5-[5-(hydroxymethyl)pyridin-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C=2N=CC(CO)=CC=2)=C1 ATOKUWJNXHKBKF-UHFFFAOYSA-N 0.000 claims 1
- JXVWNRROGBHPCT-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[5-[6-(hydroxymethyl)pyridin-3-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C=2C=NC(CO)=CC=2)=C1 JXVWNRROGBHPCT-UHFFFAOYSA-N 0.000 claims 1
- BWKAGPPKRMXSFJ-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[5-[[1-(2-hydroxyacetyl)piperidin-4-yl]methyl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(CC3CCN(CC3)C(=O)CO)ON=2)=C1 BWKAGPPKRMXSFJ-UHFFFAOYSA-N 0.000 claims 1
- IGWVIUCEGBUSEI-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[5-[[3-(hydroxymethyl)pyrrolidin-1-yl]methyl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(CN3CC(CO)CC3)ON=2)=C1 IGWVIUCEGBUSEI-UHFFFAOYSA-N 0.000 claims 1
- IWQHLJXMUPIVSX-GQWLDOHISA-N n-[(4-fluoro-3-methylphenyl)methyl]-6-[(5s)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@@H]1[C@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=C(C)C(F)=CC=2)O[C@H](CO)CO1 IWQHLJXMUPIVSX-GQWLDOHISA-N 0.000 claims 1
- CDVGIXMNPDEFMY-BEVDRBHNSA-N n-[(4-fluorophenyl)methyl]-6-[(5r)-5-[(2s,5s)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@H]1[C@@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=CC(F)=CC=2)O[C@@H](CO)CO1 CDVGIXMNPDEFMY-BEVDRBHNSA-N 0.000 claims 1
- CDVGIXMNPDEFMY-YSSFQJQWSA-N n-[(4-fluorophenyl)methyl]-6-[(5s)-5-[(2s,5s)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@H]1[C@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=CC(F)=CC=2)O[C@@H](CO)CO1 CDVGIXMNPDEFMY-YSSFQJQWSA-N 0.000 claims 1
- RUUISHLXIGXBOL-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-6-[5-[1-(2-hydroxyacetyl)piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound N=1C(C)=NC(C(=O)NCC=2C=CC(F)=CC=2)=CC=1C(C1)=NOC1C1CCN(C(=O)CO)CC1 RUUISHLXIGXBOL-UHFFFAOYSA-N 0.000 claims 1
- FALVPVBUAZQTAT-UHFFFAOYSA-N n-[(4-methoxyphenyl)methyl]-2-methyl-6-(5-phenyl-4,5-dihydro-1,2-oxazol-3-yl)pyrimidine-4-carboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC(C=2CC(ON=2)C=2C=CC=CC=2)=NC(C)=N1 FALVPVBUAZQTAT-UHFFFAOYSA-N 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 238000004806 packaging method and process Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- YPOXGDJGKBXRFP-UHFFFAOYSA-N pyrimidine-4-carboxylic acid Chemical compound OC(=O)C1=CC=NC=N1 YPOXGDJGKBXRFP-UHFFFAOYSA-N 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1272DE2011 | 2011-04-30 | ||
| IN1272/DEL/2011 | 2011-04-30 | ||
| PCT/US2012/035832 WO2012151158A1 (en) | 2011-04-30 | 2012-04-30 | Isoxazolines as therapeutic agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014513122A JP2014513122A (ja) | 2014-05-29 |
| JP2014513122A5 true JP2014513122A5 (enExample) | 2015-06-25 |
| JP6101250B2 JP6101250B2 (ja) | 2017-03-22 |
Family
ID=47108012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014509340A Expired - Fee Related JP6101250B2 (ja) | 2011-04-30 | 2012-04-30 | 治療薬としてのイソオキサゾリン類 |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US9029409B2 (enExample) |
| EP (1) | EP2704712A4 (enExample) |
| JP (1) | JP6101250B2 (enExample) |
| KR (1) | KR20140041512A (enExample) |
| CN (1) | CN103764145A (enExample) |
| AR (1) | AR086113A1 (enExample) |
| AU (2) | AU2012250979B2 (enExample) |
| CA (1) | CA2834237A1 (enExample) |
| CL (1) | CL2013003125A1 (enExample) |
| CO (1) | CO6801765A2 (enExample) |
| CR (1) | CR20130597A (enExample) |
| DO (1) | DOP2013000251A (enExample) |
| EC (1) | ECSP13013026A (enExample) |
| GT (1) | GT201300267A (enExample) |
| IL (1) | IL229081A0 (enExample) |
| MX (1) | MX355996B (enExample) |
| MY (1) | MY163870A (enExample) |
| PE (1) | PE20141190A1 (enExample) |
| PH (2) | PH12013502218A1 (enExample) |
| RU (1) | RU2013152961A (enExample) |
| SG (1) | SG194696A1 (enExample) |
| TW (1) | TW201247657A (enExample) |
| UY (1) | UY34043A (enExample) |
| WO (1) | WO2012151158A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9593126B2 (en) * | 2012-11-21 | 2017-03-14 | Zoetis Services Llc | Synthesis of spirocyclic isoxazoline derivatives |
| WO2015034866A1 (en) * | 2013-09-05 | 2015-03-12 | Abbvie Inc. | Diastereoselective methods for synthesizing isoxazole compounds |
| WO2017012970A2 (en) * | 2015-07-17 | 2017-01-26 | Syngenta Participations Ag | Pesticidally active pyrazole derivatives |
| EP3145168A1 (en) | 2015-09-17 | 2017-03-22 | Thomson Licensing | An apparatus and a method for generating data representing a pixel beam |
| US11589586B2 (en) | 2017-08-14 | 2023-02-28 | Boehringer Ingelheim Animal Health USA Inc. | Pesticidal and parasiticidal pyrazole-isoxazoline compounds |
| WO2020048583A1 (en) * | 2018-09-04 | 2020-03-12 | F. Hoffmann-La Roche Ag | Benzothiazole compounds for the treatment of autoimmune diseases |
| US20230348450A1 (en) * | 2020-09-14 | 2023-11-02 | Genzyme Corporation | Carboxylic acid-containing compounds as modulators of bis-phosphoglycerate mutase for the treatment of sickle cell disease |
| EP4333819A1 (en) | 2021-05-03 | 2024-03-13 | Katholieke Universiteit Leuven | Treatment of pharmacoresistant epilepsy |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6090382A (en) | 1996-02-09 | 2000-07-18 | Basf Aktiengesellschaft | Human antibodies that bind human TNFα |
| CO5170501A1 (es) | 1999-04-14 | 2002-06-27 | Novartis Ag | AZOLES SUSTITUIDOS UTILES PARA EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR TNFa eIL-1 Y ENFERMEDADES DEL METABOLISMO OSEO |
| ECSP003448A (es) | 2000-04-27 | 2000-05-25 | Azoles sustituidos | |
| AU2003268064A1 (en) | 2002-08-09 | 2004-02-25 | Astrazeneca Ab | Oxadiazoles as modulators of metabotropic glutamate receptor-5 |
| US20040067985A1 (en) | 2002-10-04 | 2004-04-08 | Fortuna Haviv | Method of inhibiting angiogenesis |
| US7166609B2 (en) * | 2002-11-02 | 2007-01-23 | Sanofi-Aventis Deutschland Gmbh | Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases |
| PL375044A1 (en) | 2002-11-02 | 2005-11-14 | Sanofi-Aventis Deutschland Gmbh | Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases |
| AU2003301903A1 (en) | 2002-11-06 | 2004-06-03 | Bristol-Myers Squibb Company | Isoxazoline derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme |
| US20050004111A1 (en) * | 2003-01-03 | 2005-01-06 | Aventis Pharma Deutschland Gmbh | Selective MMP-13 inhibitors |
| US20070259874A1 (en) * | 2003-11-26 | 2007-11-08 | Palle Venkata P | Phosphodiesterase Inhibitors |
| WO2005070891A2 (en) | 2004-01-23 | 2005-08-04 | Amgen Inc | Compounds and methods of use |
| CN102558082B (zh) | 2004-03-05 | 2015-09-30 | 日产化学工业株式会社 | 异噁唑啉取代苯甲酰胺化合物的制备中间体 |
| DE102004023635A1 (de) | 2004-05-10 | 2006-04-13 | Grünenthal GmbH | Heteroarylsubstituierte Cyclohexyl-1,4-diamin-Derivate |
| NZ590359A (en) | 2005-01-25 | 2012-08-31 | Synta Pharmaceuticals Corp | Pyrazine compounds for inflammation and immune-related uses |
| MX2008002014A (es) | 2005-08-15 | 2008-03-27 | Hoffmann La Roche | Derivados de piperidina y piperazina como antagonistas de p2x3. |
| US7964624B1 (en) | 2005-08-26 | 2011-06-21 | Vertex Pharmaceuticals Incorporated | Inhibitors of serine proteases |
| CN101330828A (zh) * | 2005-12-14 | 2008-12-24 | 杜邦公司 | 用于防治无脊椎害虫的异噁唑啉 |
| JP2009519937A (ja) * | 2005-12-14 | 2009-05-21 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー | 無脊椎有害生物防除用イソオキサゾリン |
| WO2007069773A1 (en) | 2005-12-15 | 2007-06-21 | Shionogi & Co., Ltd. | A pharmaceutical composition comprising an amide derivative |
| TWI412322B (zh) * | 2005-12-30 | 2013-10-21 | Du Pont | 控制無脊椎害蟲之異唑啉 |
| CA2635580A1 (en) * | 2005-12-30 | 2007-07-12 | Alantos Pharmaceuticals Holding, Inc. | Substituted bis-amide metalloprotease inhibitors |
| WO2007123855A2 (en) | 2006-04-20 | 2007-11-01 | E. I. Du Pont De Nemours And Company | Pyrazolines for controlling invertebrate pests |
| KR101810348B1 (ko) | 2006-12-26 | 2017-12-18 | 랜티우스 메디컬 이메징, 인크. | 심장 신경 분포의 영상화를 위한 리간드 |
| US8623875B2 (en) * | 2007-06-13 | 2014-01-07 | E.I. Du Pont De Nemours And Company | Isoxazoline insecticides |
| US20090035381A1 (en) | 2007-08-01 | 2009-02-05 | Stankus John J | Electrospraying method for fabrication of particles and coatings and treatment methods thereof |
| JP2010535192A (ja) * | 2007-08-02 | 2010-11-18 | ファイザー・インク | ピリミジンおよびピリジン誘導体ならびにその薬学的な使用および組成物 |
| CN101778833A (zh) | 2007-08-10 | 2010-07-14 | 日本曹达株式会社 | 含氮杂环化合物和有害生物防除剂 |
| EP2185337A4 (en) | 2007-09-12 | 2014-12-03 | Univ Washington | PROCESS FOR BLOWING CELLULAR THERMOPLASTIC SOLIDS |
| JP5552430B2 (ja) | 2007-10-31 | 2014-07-16 | メルク・シャープ・アンド・ドーム・コーポレーション | 疼痛の治療用としてのｐ２ｘ３受容体アンタゴニスト |
| TWI411395B (zh) * | 2007-12-24 | 2013-10-11 | Syngenta Participations Ag | 殺蟲化合物 |
| JP2009286773A (ja) * | 2008-03-14 | 2009-12-10 | Bayer Cropscience Ag | 殺虫性縮環式アリール類 |
| KR20110002492A (ko) | 2008-05-01 | 2011-01-07 | 비타이 파마슈티컬즈, 인코포레이티드 | 11베타-하이드록시스테로이드 탈수소효소 1의 고리형 억제제 |
| UY31881A (es) | 2008-06-10 | 2010-01-29 | Abbott Lab | Derivados sustituidos de imidazo[1,5-a]pirrolo[2,3-e]pirazinas e imidazo[1,2-a]pirrolo[2,3-e]pirazinas, sus sales, prodrogas, metabolitos biológicalmente activos, estereoisómeros e isómeros farmacéuticamente aceptables. |
| WO2010010187A1 (en) | 2008-07-25 | 2010-01-28 | Galapagos Nv | Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| BRPI0917369A2 (pt) | 2008-08-22 | 2015-08-04 | Syngenta Participations Ag | Compostos inseticidas |
| WO2010045191A2 (en) | 2008-10-13 | 2010-04-22 | Vuelogic, Llc | Methods and systems for customer performance scoring |
| EP2344480A1 (en) | 2008-10-15 | 2011-07-20 | Boehringer Ingelheim International GmbH | Fused heteroaryl diamide compounds useful as mmp-13 inhibitors |
| EP2860178B1 (en) | 2008-10-31 | 2021-01-13 | Merck Sharp & Dohme Corp. | P2X3 receptor antagonists for treatment of pain |
| ES2395704T3 (es) * | 2008-12-19 | 2013-02-14 | Novartis Ag | Derivados de isoxazolina y su uso como pesticida |
| BRPI1007310A2 (pt) | 2009-01-22 | 2015-08-25 | Syngenta Participations Ag | Compostos inseticidas. |
| US20120030841A1 (en) * | 2009-04-01 | 2012-02-02 | Basf Se | Isoxazoline compounds for combating invertebrate pests |
| US20120022058A1 (en) | 2009-04-10 | 2012-01-26 | Pfizer Inc. | 4,5-dihydro-1h-pyrazole compounds and their pharmaceutical uses |
| GB0910003D0 (en) | 2009-06-11 | 2009-07-22 | Univ Leuven Kath | Novel compounds for the treatment of neurodegenerative diseases |
| FR2948939B1 (fr) | 2009-08-05 | 2013-03-22 | Pf Medicament | Derives de 2h pyridazin-3-ones, leur preparation et leur application en therapeutique humaine |
| TWI487486B (zh) | 2009-12-01 | 2015-06-11 | Syngenta Participations Ag | 以異唑啉衍生物為主之殺蟲化合物 |
| GB2481118A (en) | 2010-06-09 | 2011-12-14 | Syngenta Participations Ag | Pesticidal mixtures comprising enantiomerically enriched isoxazoline derivatives |
| JP5972868B2 (ja) * | 2010-06-15 | 2016-08-17 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ | アントラニル酸ジアミド誘導体 |
| DK178277B1 (da) * | 2010-06-18 | 2015-10-26 | Novartis Tiergesundheit Ag | Diaryloxazolinforbindelser til bekæmpelse af fiskelus |
| AU2012215440B2 (en) * | 2011-02-10 | 2015-08-27 | Novartis Tiergesundheit Ag | Isoxazoline derivatives for controlling invertebrate pests |
-
2012
- 2012-04-26 AR ARP120101453 patent/AR086113A1/es unknown
- 2012-04-27 UY UY34043A patent/UY34043A/es not_active Application Discontinuation
- 2012-04-30 WO PCT/US2012/035832 patent/WO2012151158A1/en not_active Ceased
- 2012-04-30 JP JP2014509340A patent/JP6101250B2/ja not_active Expired - Fee Related
- 2012-04-30 US US13/460,158 patent/US9029409B2/en active Active
- 2012-04-30 MY MYPI2013702036A patent/MY163870A/en unknown
- 2012-04-30 CA CA 2834237 patent/CA2834237A1/en not_active Abandoned
- 2012-04-30 KR KR20137031865A patent/KR20140041512A/ko not_active Withdrawn
- 2012-04-30 RU RU2013152961/04A patent/RU2013152961A/ru not_active Application Discontinuation
- 2012-04-30 SG SG2013080379A patent/SG194696A1/en unknown
- 2012-04-30 CN CN201280031389.5A patent/CN103764145A/zh active Pending
- 2012-04-30 TW TW101115419A patent/TW201247657A/zh unknown
- 2012-04-30 PE PE2013002428A patent/PE20141190A1/es not_active Application Discontinuation
- 2012-04-30 AU AU2012250979A patent/AU2012250979B2/en not_active Ceased
- 2012-04-30 EP EP12779959.1A patent/EP2704712A4/en not_active Withdrawn
- 2012-04-30 MX MX2013012686A patent/MX355996B/es active IP Right Grant
- 2012-04-30 PH PH1/2013/502218A patent/PH12013502218A1/en unknown
-
2013
- 2013-10-24 IL IL229081A patent/IL229081A0/en unknown
- 2013-10-29 DO DO2013000251A patent/DOP2013000251A/es unknown
- 2013-10-29 CL CL2013003125A patent/CL2013003125A1/es unknown
- 2013-10-30 GT GT201300267A patent/GT201300267A/es unknown
- 2013-10-31 CO CO13258866A patent/CO6801765A2/es unknown
- 2013-11-15 EC ECSP13013026 patent/ECSP13013026A/es unknown
- 2013-11-15 CR CR20130597A patent/CR20130597A/es unknown
-
2015
- 2015-04-27 US US14/696,680 patent/US20150297596A1/en not_active Abandoned
- 2015-10-26 AU AU2015246181A patent/AU2015246181A1/en not_active Abandoned
-
2016
- 2016-05-05 PH PH12016500838A patent/PH12016500838A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014513122A5 (enExample) | ||
| JP6017313B2 (ja) | 化合物および方法 | |
| RU2016102137A (ru) | Первичные карбоксамиды в качестве ингибиторов bik | |
| ES2629414T3 (es) | Derivados de tiazol | |
| US8981084B2 (en) | Oxadiazole HDAC inhibitors | |
| JP2017512794A5 (enExample) | ||
| JP2016523911A5 (enExample) | ||
| RU2016141646A (ru) | Ингибиторы trka киназы, основанные на них композиции и способы | |
| JP2020516671A5 (enExample) | ||
| JP2010533158A5 (enExample) | ||
| RU2019132212A (ru) | Селективные ингибиторы hdac6 | |
| JP6500010B2 (ja) | 新規ピリジン誘導体 | |
| JP2014525444A5 (enExample) | ||
| JP2018507234A5 (enExample) | ||
| JP2007510689A5 (enExample) | ||
| JP2011503166A5 (enExample) | ||
| JP2007523142A5 (enExample) | ||
| CA2630269A1 (en) | Inhibitors of diacyglycerol acyltransferase (dgat) | |
| JP2008501673A5 (enExample) | ||
| JP2010540462A5 (enExample) | ||
| RU2015111133A (ru) | Ингибиторы тирозинкиназы брутона | |
| TW202045498A (zh) | 作為法尼醇x受體調節劑之經取代雙環化合物 | |
| JP2017523223A5 (enExample) | ||
| RU2013152961A (ru) | Изоксазолины в качестве терапевтических агентов | |
| JP2014523400A5 (enExample) |